medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2016, Número 4

<< Anterior Siguiente >>

Rev Invest Clin 2016; 68 (4)


Estimation of the Cost-Effectiveness of Breast Cancer Screening Using Mammography in Mexico Through a Simulation

Ulloa-Pérez E, Mohar-Betancourt A, Reynoso-Noverón N

Idioma: Ingles.
Referencias bibliográficas: 26
Paginas: 184-191
Archivo PDF: 88.93 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr [Accessed 16 December 2015].

  2. Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol. 2011;12:387-98.

  3. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública (MX), 2012.

  4. Ulloa, E. Github. 2015 Reproducibility Cost Effectiveness. Available at: https://github.com/ernesto-up/Reproducibility-Cost- Effectiveness

  5. Unger-Saldaña K, Miranda A, Zarco-Espinosa G, Mainero-Ratchelous F, Bargallo-Rocha E, Lázaro-León JM. Health system delay and its effect on clinical stage of breast cancer: Multicenter study. Cancer. 2015;121:2198-206.

  6. Tan-Torres Edejer T, Baltussen R, Adam T, et al. WHO Guide to Cost-Effectiveness Analysis. WHO, Geneva; 2003

  7. Secretaría de Gobernación. Projections of the population of Mexico from 2010 to 2050. Methodological document. Mexico, 2012. Available at: http://www.conapo.gob.mx/work/models/ CONAPO/Proyecciones/Documento_Metodologico/HTML/ files/assets/common/downloads/publication.pdf [Accessed 22 July 2015].

  8. Bray F, Ren JS, Masuyer E, Ferlay J. Estimates of global cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133-45.

  9. Instituto Nacional de Estadística y Geografía. Mujeres y Hombres en México 2013. México: INEGI Available at: http://www. inegi.org.mx/prod_serv/contenidos/espanol/bvinegi/productos/ integracion/sociodemografico/mujeresyhombres/2013/ Myh_2013.pdf [Accessed 21 November 2015].

  10. Duffy SW, Gabe R. What should the detection rates of cancers be in breast screening programmes? Br J Cancer. 2005;92:597-600.

  11. Tabár L, Vitak B, Chen HH, et al. The Swedish Two-Country Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000; 38:625-51.

  12. Ohta K, Kasahara Y, Tanaka F, Maeda H. Is clinical breast examination effective in Japan? Consideration from the age-specific performance of breast cancer screening combining mammography with clinical breast examination. Breast Cancer. 2016;23:183-9.

  13. Xie Y. knitr: A general-purpose package for dynamic report generation in R, R package version 1.10.5; 2015. Available at: http://yihui.name/knitr/ [Accessed 18 November 2015].

  14. Devleesschauwer B, Havelaar AH, Maertens de Noordhout C, et al. Calculating disability-adjusted life years to quantify burden of disease. Int J Public Health. 2014;59:565-9.

  15. Kruijshaar ME, Barendregt JJ; European Disability Weights Group. The breast cancer related burden of morbidity and mortality in six European countries: The European Disability Weights project. Eur J Public Health. 2004;14:141-6.

  16. World Health Organization. Global Burden of Disease 2004 update: Disability weights for diseases and conditions. Geneva: WHO 2004. Available at: http://www.who.int/healthinfo/global_ burden_disease/GBD2004_DisabilityWeights.pdf [Accessed 21 November 2015].

  17. Comisión Nacional de Protección Social en Salud. Informe del Resultado de la Fiscalización Superior de la Cuenta Pública. 2012. Available at: http://www.asf.gob.mx/Trans/Informes/ IR2012i/Documentos/Auditorias/2012_0288_a.pdf [Accessed 30 July 2015].

  18. The World Bank. GDP per capita. Available at: http://data. worldbank.org/indicator/NY.GDP.PCAP.CD [Accessed 30 September 2015].

  19. Taghipour S, Banjevic D, Miller AB, Montgomery N, Jardine AK, Harvey BJ. Parameter estimates for invasive breast cancer progression in the Canadian National Breast Screening Study. Br J Cancer. 2013;108:542-8.

  20. Anderson BO, Yip CH, Smith RA, et al. Guideline implementation for breast healthcare in low-income and middle-income countries. Cancer. 2008;113:2221-43.

  21. Secretaría de Salud. Norma Oficial Mexicana NOM-041-SSA2- 2002, para la Prevención, Diagnóstico, Tratamiento, Control y Vigilancia Epidemiológica del Cáncer de Mama. Available at: http://www.salud.gob.mx/unidades/cdi/nom/041ssa202.html [Accessed 30 July 2015].

  22. National Cancer Institute. International Cancer Screening Network. Aug 2015. Available at: http://healthcaredelivery.cancer. gov/icsn/breast/screening.html [Accessed 24 April 2015].

  23. Zelle SG, Vidaurre T, Abugattas JE, et al. Cost-effectiveness analysis of breast cancer control interventions in Peru. PLoS One. 2013;8:e82575.

  24. World Health Organization. Breast Cancer Screening. International Agency for Research on Cancer. Lyon: IARC Press; 2002.

  25. Valencia-Mendoza A, Sánchez-González G, Bautista-Arredondo S, Torres Mejía G, Bertozzi SM. [Cost-effectiveness of breast cancer screening policies in Mexico]. Salud Publica Mex. 2009; 51(Suppl 2):296-304.

  26. Niëns LM, Zelle SG, Gutiérrez-Delgado C, et al. Cost-effectiveness of breast cancer control strategies in Central America: the cases of Costa Rica and Mexico. Plos One. 2014;9:e95836.




2020     |     www.medigraphic.com